195 related articles for article (PubMed ID: 9398721)
21. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
Koch CA; Huang SC; Zhuang Z; Stolle C; Azumi N; Chrousos GP; Vortmeyer AO; Pacak K
Oncogene; 2002 Jan; 21(3):479-82. PubMed ID: 11821960
[TBL] [Abstract][Full Text] [Related]
22. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx.
Gimm O
Fam Cancer; 2005; 4(1):17-23. PubMed ID: 15883706
[TBL] [Abstract][Full Text] [Related]
23. Germline mutations in the vhl gene in patients presenting with phaeochromocytomas.
van der Harst E; de Krijger RR; Dinjens WN; Weeks LE; Bonjer HJ; Bruining HA; Lamberts SW; Koper JW
Int J Cancer; 1998 Jul; 77(3):337-40. PubMed ID: 9663592
[TBL] [Abstract][Full Text] [Related]
24. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the cysteine-rich region of the RET proto-oncogene in patients diagnosed as having sporadic medullary thyroid carcinoma.
Kimura T; Yoshimoto K; Yokogoshi Y; Saito S
Endocr J; 1995 Aug; 42(4):517-25. PubMed ID: 8556059
[TBL] [Abstract][Full Text] [Related]
26. Absence of RET proto-oncogene mutations in a father and son with pheochromocytoma and pancreatic islet cell tumor.
Kawasaki T; Tomita Y; Takahashi H; Takeda M; Tanaka H; Tamiya Y; Takahashi K
Int J Urol; 1997 Mar; 4(2):169-71. PubMed ID: 9179691
[TBL] [Abstract][Full Text] [Related]
27. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
[TBL] [Abstract][Full Text] [Related]
28. The pressure rises: update on the genetics of phaeochromocytoma.
Maher ER; Eng C
Hum Mol Genet; 2002 Oct; 11(20):2347-54. PubMed ID: 12351569
[TBL] [Abstract][Full Text] [Related]
29. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
[TBL] [Abstract][Full Text] [Related]
30. Genetic testing for pheochromocytoma-associated syndromes.
Pawlu C; Bausch B; Reisch N; Neumann HP
Ann Endocrinol (Paris); 2005 Jun; 66(3):178-85. PubMed ID: 15988378
[TBL] [Abstract][Full Text] [Related]
31. Frequent genetic changes in childhood pheochromocytomas.
De Krijger RR; Petri BJ; Van Nederveen FH; Korpershoek E; De Herder WW; De Muinck Keizer-Schrama SM; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():166-76. PubMed ID: 17102083
[TBL] [Abstract][Full Text] [Related]
32. Somatic mosaicism in von Hippel-Lindau Disease.
Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G
Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832
[TBL] [Abstract][Full Text] [Related]
33. Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomas.
Waldmann J; Langer P; Habbe N; Fendrich V; Ramaswamy A; Rothmund M; Bartsch DK; Slater EP
Endocrine; 2009 Jun; 35(3):347-55. PubMed ID: 19399650
[TBL] [Abstract][Full Text] [Related]
34. Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.
Dahia PL; Toledo SP; Mulligan LM; Maher ER; Grossman AB; Eng C
Cancer Res; 1997 Jan; 57(2):310-3. PubMed ID: 9000574
[TBL] [Abstract][Full Text] [Related]
35. [Germline gene testing of the RET, VHL, SDHD and SDHB genes in patients with pheochromocytoma/paraganglioma].
Wu K; Zhang Y; Zhang H; Tan ZH; Guo XH; Yang JM
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):634-639. PubMed ID: 30122763
[TBL] [Abstract][Full Text] [Related]
36. Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene.
Cybulski C; Krzystolik K; Murgia A; Górski B; Debniak T; Jakubowska A; Martella M; Kurzawski G; Prost M; Kojder I; Limon J; Nowacki P; Sagan L; Białas B; Kałuza J; Zdunek M; Omulecka A; Jaskólski D; Kostyk E; Koraszewska-Matuszewska B; Haus O; Janiszewska H; Pecold K; Starzycka M; Słomski R; Cwirko M; Sikorski A; Gliniewicz B; Cyryłowski L; Fiszer-Maliszewska Ł; Gronwald J; Tołoczko-Grabarek A; Zajaczek S; Lubiński J
J Med Genet; 2002 Jul; 39(7):E38. PubMed ID: 12114495
[No Abstract] [Full Text] [Related]
37. The RET proto-oncogene in sporadic pheochromocytomas.
Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
Intern Med; 1996 Jun; 35(6):449-52. PubMed ID: 8835594
[TBL] [Abstract][Full Text] [Related]
38. Incidence and clinical relevance of RET proto-oncogene germline mutations in pheochromocytoma patients.
Januszewicz A; Neumann HP; Loń I; Szmigielski C; Symonides B; Kabat M; Apel TW; Wocial B; Lapiński M; Januszewicz W
J Hypertens; 2000 Aug; 18(8):1019-23. PubMed ID: 10953992
[TBL] [Abstract][Full Text] [Related]
39. Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma.
Meyer-Rochow GY; Smith JM; Richardson AL; Marsh DJ; Sidhu SB; Robinson BG; Benn DE
J Surg Res; 2009 Nov; 157(1):55-62. PubMed ID: 19215943
[TBL] [Abstract][Full Text] [Related]
40. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER
Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
